Yahoo Web Search

Search results

1. www.dupixent.comTake Action With DUPIXENT® (dupilumab)

   www.dupixent.com

   • Cached

   TRANSCRIPT. VO: DUPIXENT® (dupilumab) is a prescription medicine used to treat people aged 6 years and older with moderate-to-severe atopic dermatitis (eczema) that is not well controlled with prescription therapies used on the skin (topical), or who cannot use topical therapies.

2. www.dupixent.com › atopicdermatitis › about-dupixentHow DUPIXENT® (dupilumab) Works for Eczema

   www.dupixent.com › atopicdermatitis › about-dupixent

   • Cached

   DUPIXENT is a biologic that works by targeting an underlying source of inflammation that could be a root cause of your uncontrolled moderate-to-severe eczema. DUPIXENT helps you stay ahead of symptoms by continuously treating eczema, even between flare-ups.

3. www.healthline.com › health › drugsDupixent (Dupilumab): Side Effects, Cost, and More - Healthline

   www.healthline.com › health › drugs

   • Cached

   Oct 12, 2023 · Dupixent is a drug for eczema and asthma that may have some side effects. Learn more about its benefits and risks from Healthline.

4. www.fda.gov › news-events › press-announcementsFDA approves new eczema drug Dupixent | FDA - U.S. Food and ...

   www.fda.gov › news-events › press-announcements

   • Cached

   Dupixent can be used with or without topical corticosteroids. Dupixent is intended for patients whose eczema is not controlled adequately by topical therapies, or those for whom topical therapies ...

5. www.mayoclinic.org › diseases-conditions › atopicAtopic dermatitis (eczema) - Diagnosis and treatment - Mayo ...

   www.mayoclinic.org › diseases-conditions › atopic

   • Cached

   May 15, 2024 · Other options for severe eczema. The injectable biologics (monoclonal antibodies) dupilumab (Dupixent) and tralokinumab (Adbry) might be options for people with moderate to severe disease who don't respond well to other treatment.

6. www.nejm.org › doi › fullDupilumab Treatment in Adults with Moderate-to-Severe Atopic ...

   www.nejm.org › doi › full

   Jul 10, 2014 · Dupilumab, a fully human monoclonal antibody that blocks interleukin-4 and interleukin-13, has shown efficacy in patients with asthma and elevated eosinophil levels. The blockade by dupilumab of th...

7. eczema.org › information-and-advice › treatments-forDupilumab | Eczema Treatment | Eczema.org

   eczema.org › information-and-advice › treatments-for

   • Cached

   Introduction. Dupilumab, also known as Dupixent®, is a treatment for moderate to severe atopic eczema (also known as atopic dermatitis) in adults and children aged 12 years and older. It’s also used to treat severe atopic eczema in children aged 6 months to 11 years. Dupilumab is a type of biologic drug called a monoclonal antibody.